OrthoPediatrics (FRA:2X7) E10: €-1.87 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2X7 OrthoPediatrics Corp FRA:2X7
84 GF Score
Price €21.40
GF Value €25.81
! 7 Warning Signs
View Full Analysis

What is OrthoPediatrics E10?

OrthoPediatrics FRA:2X7 +5.94% 84 E10 is €-1.87 as of Jun. 2026. GuruFocus rates FRA:2X7 with a GF Score™ of 84/100 and a GF Value™ of €25.81. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

OrthoPediatrics's adjusted earnings per share data for the three months ended in Jun. 2026 was €-0.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.87 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-16), OrthoPediatrics's current stock price is €21.40. OrthoPediatrics's E10 for the quarter that ended in Jun. 2026 was €-1.87. OrthoPediatrics's Shiller PE Ratio of today is .


OrthoPediatrics  (FRA:2X7) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


OrthoPediatrics E10 Related Terms


OrthoPediatrics E10 Historical Data

* Premium members only.

The historical data trend for OrthoPediatrics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrthoPediatrics E10 Chart

OrthoPediatrics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.73

OrthoPediatrics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.74 -1.76 -1.73 -1.74 -1.87

FRA:2X7 vs NPCE, VREX, OFIX: E10 Comparison

For the Medical Devices subindustry, OrthoPediatrics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrthoPediatrics Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's Shiller PE Ratio falls into.


FRA:2X7
84GF Score
OrthoPediatrics Corp FRA:2X7
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrthoPediatrics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OrthoPediatrics's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.26/333.9520*333.9520
=-0.260

Current CPI (Jun. 2026) = 333.9520.

OrthoPediatrics Quarterly Data

per share eps CPI Adj_EPS
201609 -0.285 241.428 -0.394
201612 -0.659 241.432 -0.912
201703 -1.449 243.801 -1.985
201706 -0.322 244.955 -0.439
201709 -0.210 246.819 -0.284
201712 -3.676 246.524 -4.980
201803 -0.333 249.554 -0.446
201806 -0.180 251.989 -0.239
201809 -0.129 252.439 -0.171
201812 -0.167 251.233 -0.222
201903 -0.186 254.202 -0.244
201906 -0.159 256.143 -0.207
201909 -0.163 256.759 -0.212
201912 -0.324 256.974 -0.421
202003 -0.271 258.115 -0.351
202006 -0.480 257.797 -0.622
202009 -0.204 260.280 -0.262
202012 -0.600 260.474 -0.769
202103 -0.454 264.877 -0.572
202106 -0.158 271.696 -0.194
202109 -0.094 274.310 -0.114
202112 0.003 278.802 0.004
202203 -0.427 287.504 -0.496
202206 -0.019 296.311 -0.021
202209 0.879 296.808 0.989
202212 -0.330 296.797 -0.371
202303 -0.280 301.836 -0.310
202306 -0.120 305.109 -0.131
202309 -0.187 307.789 -0.203
202312 -0.266 306.746 -0.290
202403 -0.313 312.332 -0.335
202406 -0.242 314.175 -0.257
202409 -0.306 315.301 -0.324
202412 -0.659 315.605 -0.697
202503 -0.425 319.799 -0.444
202506 -0.260 322.561 -0.269
202509 -0.426 324.800 -0.438
202512 -0.367 324.054 -0.378
202603 -0.389 330.213 -0.393
202606 -0.260 333.952 -0.260

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1.87 mean?
OrthoPediatrics (FRA:2X7) has a E10 of €-1.87 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on OrthoPediatrics and its competitors.
Is OrthoPediatrics' E10 too high?
OrthoPediatrics' current E10 is €-1.87. Overall, OrthoPediatrics has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does OrthoPediatrics' E10 compare to NPCE and VREX?
OrthoPediatrics' E10 of €-1.87 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on OrthoPediatrics and its competitors. OrthoPediatrics's current E10 is €-1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrthoPediatrics stock overvalued right now?
OrthoPediatrics (FRA:2X7) has a current E10 of €-1.87. The stock's GF Value™ is €25.81, compared to a current price of €21.40 — trading 17.1% below its estimated fair value. The current E10 is €-1.87. OrthoPediatrics' overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For OrthoPediatrics (FRA:2X7), the current E10 is €-1.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrthoPediatrics (FRA:2X7) Overvalued in 2026?

Based on GuruFocus' analysis, OrthoPediatrics stock appears to be undervalued. The current stock price of €21.40 is trading 17.1% below its estimated GF Value™ of €25.81.

Key valuation signals for FRA:2X7:

  • E10: €-1.87
  • GF Value™: €25.81 vs. price of €21.40 (17.1% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the FRA:2X7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrthoPediatrics Business Description

Other Exchanges KIDS:USA
Address 2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
84GF Score

Get the complete analysis for FRA:2X7

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€25.81
GF Value